Seeing Is Believing
Currently out of the existing stock ratings of Brandon Couillard, 131 are a BUY (73.18%), 43 are a HOLD (24.02%), 5 are a SELL (2.79%).
Analyst Brandon Couillard, currently employed at WELLS FARGO, carries an average stock price target met ratio of 69.11% that have a potential upside of 17.24% achieved within 157 days. Previously, Brandon Couillard worked at JEFFERIES.
Brandon Couillard’s has documented 375 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on DHR, Danaher at 22-Oct-2025.
Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for MYGN (MYRIAD GENETICS) at 2/25/2025. The price target of $11 was fulfilled within 3 days with a profit of $0.74 (6.3%) receiving and performance score of 21.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$140
$-8.03 (-5.42%)
$130
25 days ago
(06-Oct-2025)
6/6 (100%)
$1.44 (1.04%)
38
Hold
$150
$1.97 (1.33%)
$125
30 days ago
(01-Oct-2025)
15/16 (93.75%)
$11.3 (8.15%)
128
Buy
$150
$1.97 (1.33%)
$116
1 months 17 days ago
(14-Sep-2025)
15/20 (75%)
$24.62 (19.64%)
366
Buy
$155
$6.97 (4.71%)
$165
5 months 3 days ago
(28-May-2025)
7/10 (70%)
$42.18 (37.39%)
278
Hold
$150
$1.97 (1.33%)
$147
10 months 19 days ago
(12-Dec-2024)
8/8 (100%)
$12.12 (8.79%)
99
Which stock is Brandon Couillard is most bullish on?
Which stock is Brandon Couillard is most reserved on?
What Year was the first public recommendation made by Brandon Couillard?